Recent Insider Activity Could Benefit Acadia Pharmaceuticals Inc (ACAD)
Acadia Pharmaceuticals Inc’s filing revealed that its CEO DAVIS STEPHEN unloaded Company’s shares for reported $0.47 million on Apr 08 ’24. In the deal valued at $17.87 per share,26,574 shares were sold. As a result of this transaction, DAVIS STEPHEN now holds 144,267 shares worth roughly $2.41 million. Then, Schneyer Mark C. sold 2,716 shares, […]
CEO DAVIS STEPHEN sale 26,574 shares of Acadia Pharmaceuticals Inc [ACAD]
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Acadia Pharmaceuticals Inc shares valued at $474,877 were sold by DAVIS STEPHEN on Apr 08 ’24. At $17.87 per share, DAVIS STEPHEN sold 26,574 shares. The insider’s holdings dropped to 144,267 shares worth approximately […]
Acadia Pharmaceuticals Inc (ACAD) rating reiterates by Needham
Acadia Pharmaceuticals Inc’s recently made public that its CEO DAVIS STEPHEN unloaded Company’s shares for reported $0.47 million on Apr 08 ’24. In the deal valued at $17.87 per share,26,574 shares were sold. As a result of this transaction, DAVIS STEPHEN now holds 144,267 shares worth roughly $2.43 million. Then, Schneyer Mark C. sold 2,716 […]
A company insider recently sold 26,574 shares of Acadia Pharmaceuticals Inc [ACAD]. Should You Sale?
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Acadia Pharmaceuticals Inc shares valued at $474,877 were sold by DAVIS STEPHEN on Apr 08 ’24. At $17.87 per share, DAVIS STEPHEN sold 26,574 shares. The insider’s holdings dropped to 144,267 […]
ACAD (Acadia Pharmaceuticals Inc) may reap gains as insiders became active recently
Acadia Pharmaceuticals Inc’s recently made public that its CEO DAVIS STEPHEN unloaded Company’s shares for reported $0.47 million on Apr 08 ’24. In the deal valued at $17.87 per share,26,574 shares were sold. As a result of this transaction, DAVIS STEPHEN now holds 144,267 shares worth roughly $2.47 million. Then, Schneyer Mark C. sold 2,716 […]
Negative sentiment towards ACAD reflected in surge in short interest
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Acadia Pharmaceuticals Inc shares valued at $474,877 were sold by DAVIS STEPHEN on Apr 08 ’24. At $17.87 per share, DAVIS STEPHEN sold 26,574 shares. The insider’s holdings dropped to 144,267 shares worth approximately $2.56 million following […]
Acadia Pharmaceuticals Inc [ACAD] CEO makes an insider sale of 17,714 shares worth $0.32 million.
In a filing, Acadia Pharmaceuticals Inc revealed its CEO DAVIS STEPHEN unloaded Company’s shares for reported $0.32 million on Mar 27 ’24. In the deal valued at $17.90 per share,17,714 shares were sold. As a result of this transaction, DAVIS STEPHEN now holds 118,842 shares worth roughly $2.14 million. Then, Schneyer Mark C. sold 5,434 […]